News | November 05, 2010

NICOM System Found to be Effective at Diagnosing Acute Heart Failure

November 5, 2010 - A study performed by investigators from the Emergency Department of the Cleveland Clinic Foundation found that a noninvasive cardiac output monitor (NICOM) system is effective in identification of acute heart failure (AHF). The system, by Cheetah Medical, is also effective in differentiating AHF from other acute situations with similar clinical presentations. The study was published last week in the American Journal of Emergency Medicine.

In this study, the Cheetah NICOM Noninvasive Cardiac Output and Hemodynamic Monitoring System was able to distinguish heart failure patients from patients diagnosed with COPD, asthma and dyspnea for other reasons. The FDA-cleared, non-invasive bedside test utilizes a set of four sensors placed on the patient's chest or back. The system was used to monitor patients' hemodynamics around a change in patient position, also known as "orthostatic challenge." The system accurately differentiated between heart failure and other conditions.

"Acute heart failure affects 5.8 million Americans per year, with costs exceeding $33 billion,” said Rakesh Engineer, M.D., FACEP, discipline leader, emergency and undifferentiated care at the Cleveland Clinic Lerner College of Medicine and the study's primary investigator. “Clinical judgment, even when combined with our best biomarkers, produces a diagnostic accuracy of only 82.5 percent. Clearly, new methods to determine the etiology of shortness of breath in emergency patients are needed. This study illustrates the utility of NICOM Bioreactance Technology in differentiating acute heart failure from asthma and COPD.”

"Outcomes in patients presenting to the emergency department with acute shortness of breath are related to appropriate and timely therapy,” said W. Frank Peacock, M.D., FACEP, vice chair, Emergency Medicine Institute, Cleveland Clinic Foundation and the study's senior author. “When therapy is delayed or inappropriate, the acute mortality rate is increased. Our data suggest that an early and accurate heart failure diagnosis can be determined by measuring hemodynamic changes using NICOM Technology."

For more information: www.cheetah-medical.com

Related Content

ASNC and SNMMI Release Joint Document on Diagnosis, Treatment of Cardiac Sarcoidosis
News | Cardiac Imaging| August 18, 2017
August 18, 2017 — The American Society of...
AUM Cardiovascular Receives FDA Approval for CADence ECG Device
Technology | ECG| August 08, 2017
AUM Cardiovascular announced it has received clearance from the U.S. Food and Drug Administration (FDA) for CADence, a...
New Jersey Researcher Exploring New Stem Cell Therapies for Heart Attacks
News | Stem Cell Therapies| August 04, 2017
In petri dishes in her campus laboratory at New Jersey Institute of Technology, Alice Lee is developing colonies of...
New Study Focuses on Protein Responsible For Increased Heart Disease Risk
News | Cardiac Diagnostics| August 03, 2017
August 3, 2017 — A study to reduce the strongest inherited...
Left Atrial Pressure Monitor from Vectorious Medical Technologies Offers New Hope for Heart Failure Patients

On of the top stories in July was the introduction of a left atrial pressure monitor from Vectorious Medical Technologies to prevent heart failure patient hospitalizations or readmissions. Read the article"Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients."

Feature | August 01, 2017 | Dave Fornell
Aug.
Philips released a new version of its iFR system that displays FFR readings as an overlay on live angiographic, angiogram images.

Philips released a new version of its iFR system that displays hemodynamic pressure drop points in an overlay on live angiographic images, matching up the iFR readings with corresponding lesions. The system is supposed to speed diagnostic decision making and help guide percutaneous revascularization procedures. 

Feature | FFR Catheters| July 31, 2017 | Dave Fornell
The gold standard for assessing the hemodynamic significance of coronary lesions to determine if they should be revas
Siemens Healthineers to Acquire Epocal from Alere
News | Point of Care Testing| July 26, 2017
Siemens Healthineers has entered into a definitive agreement to acquire Epocal Inc., a subsidiary of Alere Inc. Epocal...
Wearable monitors create patient generated health data, PGHD, that can help prevent acute care episodes in heart failure.

Wearable monitoring devices may offer a new tool to help prevent acute care episodes in heart failure.

Feature | Heart Failure| July 25, 2017 | Lola Koktysh
Despite their best efforts, many patients tend to develop heart failure after an acute event (e.g., a heart attack or
New PET-CT Scan Improves Detection in Rare Cardiac Condition
News | PET-CT| July 25, 2017
Using a new imaging technique that can diagnose cardiac sarcoidosis much more accurately than traditional tests,...
3-D Vascular Ultrasound Quantifies Plaque Burden to Estimate Cardiovascular Risk
News | Cardiovascular Ultrasound| July 20, 2017
July 20, 2017 — In a large, first-of-its-kind population, researchers found an experimental technique known as...
Overlay Init